Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
HealthStream Q1 2026 Earnings Call - Record Revenue and EBITDA Drive Strategic AI and Career Network Investments
HealthStream delivered a record Q1 2026, with revenue surging 10.5% year-over-year to $81.2 million and adjusted EBITDA climbing 24.1% to $20.1 million. The company reaffirmed its full-year guidance, ...
- Record Q1 2026 revenue of $81.2 million, up 10.5% year-over-year, driven by subscription growth and acquisition contributions.
- Adjusted EBITDA reached a new high of $20.1 million, representing a 24.1% year-over-year increase and a 24.8% margin.
- Full-year 2026 guidance reaffirmed: Revenue $323-$330 million, Net Income $20.4-$22.8 million, Adjusted EBITDA $73-$77 million.
- +7 more takeaways
CPS Technologies Q1 2026 Earnings Call - Inventory Build and New Facility Delay Mask Strong Backlog
CPS Technologies reported a modest 7% year-over-year revenue decline to $7 million in Q1 2026, driven by temporary order timing and a deliberate inventory build ahead of a facility relocation. Gross m...
- Q1 2026 revenue came in at $7 million, a 7% year-over-year decline from $7.5 million in Q1 2025, primarily attributed to order timing rather than weak demand.
- Gross profit fell to $0.6 million (8.6% of revenue) from $1.2 million (16.4% of revenue) last year, pressured by lower revenue and inventory build costs.
- Operating loss widened to $500,000 from a $100,000 profit last year, while net loss increased to $300,000 from $100,000 net income.
- +7 more takeaways
Sotera Health Q1 2026 Earnings Call - CEO Transition and Legal Wins Fuel Momentum
Sotera Health delivered a robust Q1 2026, posting 6.5% constant currency revenue growth and 6.9% constant currency Adjusted EBITDA growth. The standout performer was Nordion, which surged 25.8% in con...
- Q1 2026 revenue grew 6.5% on a constant currency basis, with Adjusted EBITDA up 6.9%, driving over 20 basis points of margin expansion.
- Nordion was the clear standout, with constant currency revenue surging 25.8% and margins expanding over 290 basis points, fueled by Cobalt-60 harvest timing.
- Sterigenics delivered 6.1% constant currency revenue growth, offsetting a 1.7% weather-related volume headwind with strong pricing and mix improvements.
- +7 more takeaways
BellRing Brands Q2 FY2026 Earnings Call - Promotional Intensity and Input Inflation Pressurize Margins Despite Strong Category Growth
BellRing Brands delivered a second quarter that fell short of expectations, with net sales growing just 2% while adjusted EBITDA margin collapsed to 9%, well below the 13% guide. The miss was driven b...
- Q2 FY2026 net sales grew 2% to $599 million, but adjusted EBITDA margin fell to 9%, missing the 13% guide by 400 basis points due to mix deterioration and higher costs.
- Premier Protein RTD shake volumes surged 12%, but unfavorable price mix of 9% offset gains, as 27% of category volume was sold on promotion, up 8 percentage points year-over-year.
- Management cited a 'perfect storm' of competitive intensity, consumer trade-down, and macro-driven cost inflation, with protein and freight costs accelerating sharply in the latter part of the quarter.
- +7 more takeaways
Lindblad Expeditions Holdings, Inc. Q1 2026 Earnings Call - Record Yields and Booking Momentum Defy Geopolitical Headwinds
Lindblad Expeditions delivered another record quarter despite severe weather disruptions in Antarctica and geopolitical fallout from the war in Iran. The company achieved a historic 93% first quarter ...
- Record Q1 occupancy of 93% on 6% capacity growth, driving a 7% net yield increase to $1,631 per available guest night.
- Total revenues grew 16% to $208 million, with Lindblad segment up 16% and Land Experiences up 14%.
- Adjusted EBITDA rose 16% to $34.8 million, while net income turned positive at $6 million compared to a loss last year.
- +12 more takeaways
Metallus Q1 2026 Earnings Call - Defense Run Rate and Tariff Tailwinds Drive Profitability
Metallus delivered a strong first quarter in 2026, with adjusted EBITDA rising 39% year-over-year to $24.6 million and shipments climbing 11% sequentially. The growth was fueled by a robust order book...
- Adjusted EBITDA surged 39% year-over-year to $24.6 million, driven by higher shipments, improved price mix, and better raw material spreads.
- Net sales reached $308.3 million, a 10% increase year-over-year, with shipments up 11% sequentially across most end markets.
- Order book grew significantly year-over-year, with lead times expanding into the late third quarter for bars and seamless mechanical tubing, signaling strong demand momentum.
- +7 more takeaways
IDEXX Laboratories Q1 2026 Earnings Call - IDEXX Raises Full-Year Guidance on CAG Diagnostics Growth and InViewDX Momentum
IDEXX Laboratories delivered a strong start to 2026, driving a full-year revenue and EPS guidance raise fueled by double-digit organic growth in companion animal diagnostics and robust international e...
- Full-year revenue guidance raised to $4.675B-$4.760B, reflecting an 8.6%-10.6% reported growth range and a $32M midpoint improvement.
- Full-year EPS guidance increased to $14.45-$14.90, up $0.13 at midpoint, driven by operational performance and margin expansion.
- Q1 2026 organic revenue grew 11%, with CAG Diagnostics recurring revenue up 11% organically, supported by 11% U.S. and 12% international growth.
- +9 more takeaways
Waters Corporation Q1 2026 Earnings Call - Raised Full-Year Guidance on Synergy Execution and Acquired Business Turnaround
Waters Corporation delivered a strong first quarter of 2026, combining double-digit organic growth in its legacy business with a significant turnaround in its newly acquired BD Biosciences and Diagnos...
- Total reported revenue reached $1.267 billion, with organic revenue growing 13% as reported (11% constant currency), beating the high end of guidance by 200 basis points.
- Adjusted EPS grew 20% year-over-year to $2.70, exceeding the high end of the guidance range by $0.35, driven by top-line strength and disciplined cost management.
- The acquired BD Biosciences and Diagnostic Solutions businesses delivered $520 million in revenue, beating guidance by $40 million and showing estimated as-reported growth of 7%.
- +7 more takeaways
IAC Q1 2026 Earnings Call - IAC Renames to People Inc. as Core Publishing Business Accelerates Non-Session Revenue Growth
IAC delivered a solid first quarter, with People Inc. digital revenue up 8% and digital adjusted EBITDA margins expanding to 20%. The company is aggressively pivoting away from traditional web session...
- IAC digital revenue grew 8% in Q1 2026, marking the 10th consecutive quarter of growth, while digital adjusted EBITDA margins expanded to 20% from 18% year-over-year.
- Non-session-based revenue surged 24% year-over-year, now representing 41% of People Inc. digital revenue, driven by AI targeting, social programs, Apple News, and licensing deals.
- IAC announced it will rebrand as People Incorporated, consolidating corporate functions and eliminating the duplicate IAC parent layer to generate $40 million in annual run-rate savings.
- +7 more takeaways
Rockwell Automation Q2 FY2026 Earnings Call - Data Center & Warehouse Automation Drive Double-Digit Growth
Rockwell Automation delivered a standout second quarter in fiscal 2026, with organic sales growing 9% and adjusted EPS jumping 30% to $3.30, significantly beating expectations. The growth was broad-ba...
- Organic sales grew 9% year-over-year, with reported sales up 12%, driven by strong performance across multiple end markets and favorable currency translation contributing 3 points.
- Adjusted EPS surged 30% to $3.30, beating expectations, supported by higher volume, positive price-cost dynamics, favorable mix, and productivity gains.
- Data center sales more than doubled year-over-year, emerging as one of the strongest end markets, driven by demand for industrial-grade controllers and power distribution solutions.
- +9 more takeaways